Informations

Stand number

K49

Exhibition class

M: Medicine – Surgery – Orthopaedics – Material for disabled

Technical description

Nanodrug that use alginate chitosan nanoparticles to release HOCl at lung cancer sites, ensuring targeted therapy. It assesses folate conjugation, HOCl release, cytotoxicity, protein expression, and in vivo effects in mice.

Simplified description

This invention introduces a nanodrug designed to treat lung cancer. Using tiny particles made from alginate and chitosan, it delivers a substance called HOCl directly to cancerous areas in the lungs, making the treatment more precise. The study examines how effectively the drug targets cancer cells, how it affects cell proteins, and how well it works in mice.